Koppeschaar HP - Search Results

1

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M. Sjöström L, et al. Among authors: koppeschaar hp. Lancet. 1998 Jul 18;352(9123):167-72. doi: 10.1016/s0140-6736(97)11509-4. Lancet. 1998. PMID: 9683204 Clinical Trial.

2

[Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients].

Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar H, Krempf M; European Multicenter Orlistat Study Group. Sjostrom L, et al. Ter Arkh. 2000;72(8):50-4. Ter Arkh. 2000. PMID: 11019429 Clinical Trial. Russian.

3

Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study.

Mourits MP, van Kempen-Harteveld ML, García MB, Koppeschaar HP, Tick L, Terwee CB. Mourits MP, et al. Among authors: koppeschaar hp. Lancet. 2000 Apr 29;355(9214):1505-9. doi: 10.1016/S0140-6736(00)02165-6. Lancet. 2000. PMID: 10801172 Clinical Trial.

4

GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults.

Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C, Obradovic S, Dieguez C, Casanueva FF. Popovic V, et al. Among authors: koppeschaar hp. Lancet. 2000 Sep 30;356(9236):1137-42. doi: 10.1016/S0140-6736(00)02755-0. Lancet. 2000. PMID: 11030292 Clinical Trial.

5

The effect of fluoxetine on body weight, body composition and visceral fat accumulation.

Visser M, Seidell JC, Koppeschaar HP, Smits P. Visser M, et al. Among authors: koppeschaar hp. Int J Obes Relat Metab Disord. 1993 May;17(5):247-53. Int J Obes Relat Metab Disord. 1993. PMID: 8389333 Clinical Trial.

6

Mortality in elderly patients with subclinical hyperthyroidism.

Twickler TB, Cramer MJ, Koppeschaar HP, de Vries WR, Erkelens DW. Twickler TB, et al. Among authors: koppeschaar hp. Lancet. 2002 Mar 2;359(9308):799. doi: 10.1016/s0140-6736(02)07860-1. Lancet. 2002. PMID: 11888624 No abstract available.

7

Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity.

Pijl H, Koppeschaar HP, Willekens FL, Op de Kamp I, Veldhuis HD, Meinders AE. Pijl H, et al. Among authors: koppeschaar hp. Int J Obes. 1991 Mar;15(3):237-42. Int J Obes. 1991. PMID: 1646182 Clinical Trial.

8

Prolactinoma and body weight: a retrospective study.

Creemers LB, Zelissen PM, van 't Verlaat JW, Koppeschaar HP. Creemers LB, et al. Among authors: koppeschaar hp. Acta Endocrinol (Copenh). 1991 Oct;125(4):392-6. doi: 10.1530/acta.0.1250392. Acta Endocrinol (Copenh). 1991. PMID: 1957557

9

Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans.

Pijl H, Koppeschaar HP, Cohen AF, Iestra JA, Schoemaker HC, Frölich M, Onkenhout W, Meinders AE. Pijl H, et al. Among authors: koppeschaar hp. Int J Obes Relat Metab Disord. 1993 Sep;17(9):513-20. Int J Obes Relat Metab Disord. 1993. PMID: 8220653 Clinical Trial.

10

No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity.

Visser M, Seidell JC, Koppeschaar HP, Smits P. Visser M, et al. Among authors: koppeschaar hp. Obes Res. 1994 Mar;2(2):152-9. doi: 10.1002/j.1550-8528.1994.tb00641.x. Obes Res. 1994. PMID: 16353616 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters